Kensey Nash Looking At Smaller Angio-Seal To Boost Market Share
This article was originally published in The Gray Sheet
Executive Summary
Kensey Nash is predicting that the U.S. launch in January of a 6 Fr version of its Angio-Seal hemostatic puncture closure device will give the company a leg up on competitors Datascope (VasoSeal) and Perclose (ProStar and TechStar).